I have read all recent qrx announcements (some many times)and would love someone explain in simple layman's terminology what the relevance there is with providing the oxygen dataset to the fda.
Does it mean that without this data passing some sort of specific hurdle the moxduo treatment regime is unacceptable? Or is it just completing the entirety of the submission?
layman's explanation
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
